Evidence map›Paper›PMID 39394974›Full record

ArticleDialogues in clinical neuroscience2024

Associations between methamphetamine use disorder and

Alexandre A Guerin, Briana Spolding, Kiymet Bozaoglu, Courtney Swinton, Zoe Liu, Bruna Panizzutti Parry, Trang Truong, Brian Dean, Andrew J Lawrence, Yvonne Bonomo and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Dialogues in clinical neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Alexandre A GuerinCentre for Youth Mental, University of Melbourne, Melbourne, Australia.
Briana SpoldingIMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Australia.
Kiymet BozaogluMurdoch Children's Research Institute, Parkville, Australia.
Courtney SwintonIMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Australia.
Zoe LiuIMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Australia.
Bruna Panizzutti ParryIMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Australia.
Trang TruongIMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Australia.
Brian DeanThe Florey Institute of Neuroscience and Mental Health, Parkville, Australia.
Andrew J LawrenceThe Florey Institute of Neuroscience and Mental Health, Parkville, Australia.
Yvonne BonomoDepartment of Addiction Medicine, St Vincent's Hospital, Melbourne, Australia.
Eric J NestlerNash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Peter J HamiltonDepartment of Anatomy and Neurobiology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
Michael BerkOrygen, Melbourne, Australia.
Susan RossellCentre for Mental Health, Swinburne University of Technology, Melbourne, Australia.
Ken WalderIMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Australia.
Jee Hyun KimIMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Australia.ORCID 0000-0002-1299-4300

Funding

Transcription Factors in Stimulant and Opioid ActionP01DA047233 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI YASMIN L. HURD · 2019 to 2026
$16.5M
NIDA NIH HHS P01 DA047233
6 · The paper itself

Abstract

introductionAssessing candidate gene sequence variations and expression helps to understand methamphetamine use disorder and inform potential treatments. We investigated single nucleotide polymorphisms (SNPs) and gene expression in four candidate genes:

methodsFifty-nine participants (29 people with methamphetamine use disorder and 30 controls) completed a clinical interview, cognitive tasks, and provided a blood sample.

results

conclusions

Indexed as

AmidohydrolasesAmphetamine-Related DisordersBrain-Derived Neurotrophic FactorMethamphetaminePolymorphism, Single NucleotideAdultFatty Acid Amide HydrolasesFemaleGene ExpressionGenetic Predisposition to DiseaseGenotypeHumansMaleMiddle AgedAmidohydrolasesBDNF protein, humanBrain-Derived Neurotrophic FactorFatty Acid Amide HydrolasesMethamphetaminecognitive flexibilityendocannabinoidinhibitory controlsingle nucleotide polymorphismSubstance use disorderVMAT

Identifiers

PMID39394974
PMCPMC11486062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.